Spinal cord intramedullary tumors are rare and account for 20% of adults and 35% of pediatric spinal tumors. Astrocytomas and ependymomas are the most common histological types of intramedullary tumors (
1). As the most common intramedullary spinal cord neoplasm in adults, spinal cord intramedullary ependymomas (IE) originate from ependymal cells that line the ventricular system and spinal canal. They account for approximately 3 - 6% of central nervous system tumors and 60% of intramedullary tumors (
2). The majority of spinal cord ependymomas (25 - 42% of the cases) occur in the cervical region, and most of them are non-capsulated, benign, have little infiltrative potential, and have a slow rate of growth (
3). Before diagnosis, they cause prolonged symptoms, with an average of two years. Symptoms are related to the tumor's location and can present with pain, motor weakness of extremities, hypoesthesia, gait disturbance, sphincter, or sexual dysfunction (
4). Considering the non-specific nature of its presentation, it is imperative to conduct imaging modalities as early as possible. The use of imaging also aids in the determination of tumor size, compression of structures, and other important aspects apart from diagnosis (
5).
IEs are classified into three types. Grade I, tumors include myxopapillary and subependymoma, which do not infiltrate the peripheral tissue, and surgical excision is sufficient to be cured. Grade II, tumors have papillary, clear cell, and tanycytic cells that tend to recur after resection and can transform into malignant types more frequently than grade I tumors. Grade III tumors are anaplastic ependymomas that infiltrate adjacent tissue, and surgical resection does not cure them (
4).
The gold standard treatment choice for IE tumors is gross-total surgical resection (
6). Postoperative radiotherapy for residual tumors may be needed as surgical resection leads to complete resection because of tumor location. Still, the role of this adjuvant therapy remains unclear and is related to the extent of tumor resection. Radiotherapy decreases failure rate, enhances neurologic function, and Increases survival rate (
7). Radiation therapy should be applied to those with anaplastic-type or residual mass after the operation (
8).